Showing results (1-10 of 185) with videos related to
Sort By:
Pageof 19
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Amphiphilic oligomers: a new kind of macromolecular carrier of antimitotic drugsChristiane Contino-Pépin, MasJeanaharu Claude Maurizis, Bernard PucciCurrent Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Unusual DNA conformations: implications for telomeresMartin Mills, Laurent Lacroix, Paola B Arimondo, et al.Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Green tea catechins as novel antitumor and antiangiogenic compoundsMichel Demeule, Jonathan Michaud-Levesque, Borhane Annabi, et al.Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Design of selectively activated anticancer prodrugs: elimination and cyclization strategiesS Papot, I Tranoy, F Tillequin, et al.Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Discovery of antitumor indolocarbazoles: rebeccamycin, NSC 655649, and fluoroindolocarbazolesByron H Long, William C Rose, Dolatrai M Vyas, et al.Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Novel aspects of natural and modified vinca alkaloidsAlain Duflos, Anna Kruczynski, Jean-Marc BarretCurrent Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
X-ray crystallographic studies of CDK2, a basis for cyclin-dependent kinase inhibitor design in anti-cancer drug researchPascal FuretCurrent Medicinal Chemistry. Anti-Cancer Agents|May 29, 2003
Death receptor signaling in cancer therapySimone Fulda, Klaus-Michael DebatinCurrent Medicinal Chemistry. Anti-Cancer Agents|May 29, 2003
The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cellsWei-Guo Zhu, Gregory A OttersonCurrent Medicinal Chemistry. Anti-Cancer Agents|July 23, 2003
Disruption of cell death signaling in cancer: impact on disease prognosis and response to therapyDilek Güner, Claus Belka, Peter T DanielPageof 19